What is Acquired Resistance to Targeted Therapy, and Why Does it Occur? episode artwork

EPISODE · Dec 11, 2015 · 26 MIN

What is Acquired Resistance to Targeted Therapy, and Why Does it Occur?

from GRACEcast · host cancerGRACE Meetings

Dr. Karen Reckamp of City of Hope Cancer Center reviews the concept of acquired resistance to targeted therapies in patients with a driver mutation and why it occurs.

Episode metadata supplied by the publisher feed · Published Dec 11, 2015

Embed this episode

NOW PLAYING

What is Acquired Resistance to Targeted Therapy, and Why Does it Occur?

0:00 26:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 26 minutes long.

When was this GRACEcast episode published?

This episode was published on December 11, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!